GDNF — Drug Target

All drugs that target GDNF — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

gene therapy · Gene therapy

Phase 2 pipeline (1)

• AAV2-GDNF gene therapy · Brain Neurotherapy Bio, Inc. · gene therapy · Neurology
  AAV2-GDNF gene therapy delivers a viral vector carrying the GDNF gene to the brain, where it is expressed and promotes the survival and growth of dopaminergic neurons.

Phase 1 pipeline (1)

• AAV2-GDNF · Brain Neurotherapy Bio, Inc. · Gene therapy · Neurology
  AAV2-mediated delivery of glial cell line-derived neurotrophic factor